The purpose of this trial was to evaluate the effectiveness and safety of Naturlose
(Tagatose) for glycemic control in people with Type 2 diabetes who were not taking other
medications for the condition and who were under diet control and exercise.
The study lasted approximately one year. HbA1c was monitored every 2 months after entry into
the study. Safety and tolerance for tagatose were assessed every 2 months throughout the
study. A total of 14 visits were made to the study site.